Christopher Ryan Cave Barrett - 01 Oct 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Reporting relationship: Chief Legal and Business Officer
Issuer ticker: ATAI
Reported as of: 01 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Oct 2025, 18:24:41 UTC
Next SEC filing: 03 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Ryan Barrett

Key filing fact

Christopher Ryan Cave Barrett filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 03 Oct 2025.

Key facts

This page summarizes Christopher Ryan Cave Barrett's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Oct 2025, 18:24.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002087548 Primary reporting owner

Barrett Christopher Ryan Cave

Relationship: Chief Legal and Business Officer
Address: C/O ATAI LIFE SCIENCES N.V., PROF. J.H. BAVINCKLAAN 7, AMSTERDAM, NETHERLANDS
Signature: /s/ Ryan Barrett
Signature date: 03 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATAI transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +175,000
Change %
Price: $0.000000
Shares after: 175,000
Date: 01 Oct 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 175,000
Exercise price: $5.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.

SEC remarks

Chief Legal and Business Officer